Featured Research

from universities, journals, and other organizations

Basolateral amygdala may hold key to helping prevent drug cravings and relapse

Date:
April 16, 2012
Source:
American Association of Neurological Surgeons (AANS)
Summary:
Researchers have discovered evidence that the basolateral amygdala may play a critical role in helping to adjust the ability of conditioned hints or triggers that enhance a recovering addict’s craving or drug seeking.

According to research presented recently at the 80th Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) in Miami, researchers have discovered evidence that the basolateral amygdala may play a critical role in helping to adjust the ability of conditioned hints or triggers that enhance a recovering addict's craving or drug seeking.

Even if former addicts have ceased using drugs for a lengthy period of time, the craving/desire for those substances remains. Environmental cues that are paired with previous drug use can enhance drug seeking. At the same time, inhibitory cues associated with a drug's unavailability can reduce drug seeking. The amygdala may serve as a critical structure for these interactions.

For this study, alcohol-preferring (P) rats were exposed to the following odors: 1. an odor paired with the operant self-administration of EtOH (CS+); 2. an odor paired with the unavailability of EtOH (CS-); and 3. a neutral odor (CS 0). Subjects were then exposed to on odor for 30 minutes in a non-drug paired environment and neuronal activity was measured through standard c-fos protocols. Microinjections of GABA agonists were then used to pharmacologically silence the bilateral basolateral amygdala (BLA) of P rats in a 2 (active drug or aCSF control injection) by 3 (CS+, CS- or CS 0) experimental design in the operant setting. The results of this study, The Basolateral Amygdala is a Critical Structure for Environment Cue Augmentation of EtOH-Seeking, was presented by Jessica Wilden, MD, 2:55-3:09 p.m., on Monday on, April 16. Co-authors are Sheketha Hauser, PhD; Gerald Deehan Jr., PhD; Zheng-Ming Ding, PhD; William Truitt, PhD; William McBride, MD, PhD; and Zachary Rodd, PhD.

Though neuronal activity was not altered by the conditioned cues in the central or medial amygdala, there was a 60 percent increase in c-fos positive neurons in the basolateral amygdala in CS+ subjects. Since BLA was only activated via the excitatory conditioned cue (CS+), it was hypothesized that activation of BLA enhanced EtOH-seeking. Subsequent pharmacological silencing of the BLA did not affect baseline EtOH-seeking or the inhibitory effect of the CS-, but did prevent enhancement of EtOH-seeking invoked by CS+. Researchers concluded that BLA may mediate the ability of conditioned cues to enhance drug seeking. This region could serve as a target for intervention to reduce drug craving and relapse.


Story Source:

The above story is based on materials provided by American Association of Neurological Surgeons (AANS). Note: Materials may be edited for content and length.


Cite This Page:

American Association of Neurological Surgeons (AANS). "Basolateral amygdala may hold key to helping prevent drug cravings and relapse." ScienceDaily. ScienceDaily, 16 April 2012. <www.sciencedaily.com/releases/2012/04/120416154053.htm>.
American Association of Neurological Surgeons (AANS). (2012, April 16). Basolateral amygdala may hold key to helping prevent drug cravings and relapse. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/04/120416154053.htm
American Association of Neurological Surgeons (AANS). "Basolateral amygdala may hold key to helping prevent drug cravings and relapse." ScienceDaily. www.sciencedaily.com/releases/2012/04/120416154053.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins